Patent · US Active

Antibodies to human β-adrenergic receptor kinase

US8779106B2 · kind B2 · utility

0Cited by
18References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 30, 2012
Grant dateJul 15, 2014
Priority date—
Expiry dateJul 30, 2032

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/573
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Various embodiments of the invention provide human kinases and phosphatases (KPP) polypeptides and polynucleotides which identify and encode KPP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KPP.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.